News

REGENXBIO to Showcase Gene Therapy Innovations at Chardan Event

REGENXBIO to Showcase Gene Therapy Innovations at Chardan Event

REGENXBIO's Participation in the Genetic Medicines Conference

REGENXBIO Inc. (NASDAQ: RGNX), a leading company in gene therapy, is gearing up to take part in Chardan's 8th Annual Genetic Medicines Conference. This event provides an exciting platform for the company to highlight its novel approaches and progress in genetic treatment methods.

Conference Overview

The conference will take place on a Monday and will feature a fireside chat beginning at 8:30 a.m. ET. During this discussion, industry leaders will share insights on key trends and developments in the realm of genetic medicines. The gathering aims to connect experts, investors, and the wider community to foster the exchange of ideas within the fast-moving field of gene therapy.

REGENXBIO's Dedication to Innovation

Since its founding in 2009, REGENXBIO has made significant advancements in gene therapy with the development of AAV Therapeutics, which represent a revolutionary class of treatments. Their ongoing research focuses on retinal and rare diseases. For example, ABBV-RGX-314 targets wet AMD and diabetic retinopathy, produced in collaboration with AbbVie. Their ambitious development pipeline also includes RGX-202, which is aimed at treating Duchenne muscular dystrophy, and RGX-121 for MPS II.

The Importance of AAV Therapeutics

AAV Therapeutics aim to provide long-lasting solutions for patients, potentially serving as one-time treatments that could significantly alter healthcare delivery. This platform has already had a positive impact on many patients, highlighted by notable successes like Novartis’ ZOLGENSMA, which treats spinal muscular atrophy in children.

How to Join the Conference

If you're interested in following the updates from the conference, a live webcast of the fireside chat will be accessible through the Investors section of REGENXBIO's website. An archived version will also be available online for those who can’t catch the event live.

About REGENXBIO Inc.

REGENXBIO is committed to harnessing the curative potential of gene therapy to change the lives of patients. Their innovative contributions in AAV Therapeutics consistently place them at the leading edge of biotechnology, making vital strides in the treatment of various severe health conditions. As new breakthroughs occur, REGENXBIO remains focused on enhancing healthcare outcomes for individuals around the globe.

Frequently Asked Questions

What does REGENXBIO specialize in?

REGENXBIO focuses on developing AAV Therapeutics for genetic diseases and retinal disorders.

When is Chardan's Annual Genetic Medicines Conference held?

The conference is on a Monday, kicking off with a fireside chat at 8:30 a.m. ET.

How does REGENXBIO impact gene therapy?

The company leads in creating innovative gene therapies that aim to offer lasting solutions for genetic disorders, often collaborating with other pharmaceutical companies.

Where can I view the conference online?

You can watch a live webcast of the conference on REGENXBIO's official website.

What key products has REGENXBIO developed?

REGENXBIO is advancing several programs, including ABBV-RGX-314 for retinal conditions, as well as treatments aimed at Duchenne muscular dystrophy and MPS II.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 166

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Karma Automotive Debuts High-Stakes Eximius Program

Updated Category News Views 178

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 179

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 27

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 84

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 126

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
GAC Dominates with 8 Awards in Cutting-Edge Tech

Updated Category News Views 225

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Continue Reading
Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 0

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading
SKYWORTH Solar's Solavita: Energizing Global Microgrids

Updated Category News Views 109

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

Continue Reading

Top 5 Most Recently Viewed Articles

Aligos Therapeutics Shows Positive Progress with New Study Results

Updated Category News Views 160

Positive Developments in Aligos Therapeutics Clinical Trials Aligos Therapeutics Inc. (NASDAQ: ALGS) has recently made a splash in the news. H.C. Wainwright has reasserted a Buy rating and set a price target of $75.00 following encouraging results from the company's Phase 2a HERALD study, which explores treatments for metabolic-associated steatohepatitis (MASH). The...

Continue Reading
Grand Canal Expo Highlights: Culture, Innovation, and Future

Updated Category News Views 140

Grand Canal Culture and Tourism Expo Unveiled The 6th Grand Canal Culture and Tourism Expo was an extraordinary event that celebrated a wide array of cultural expressions and cutting-edge technologies. Organized by the Jiangsu Provincial Department of Culture and Tourism, it drew over 130,000 enthusiastic attendees and reached around 500 million viewers online from all...

Continue Reading
Eli Lilly Transitions from CVS to New Drug Benefits Provider

Updated Category News Views 292

Eli Lilly Changes Pharmacy Benefits Providers Eli Lilly & Co. (NYSE: LLY) has announced a significant shift in its drug benefit plan for employees by dropping CVS Health Inc. (NYSE: CVS) as its pharmacy benefits provider. This change is set to take effect on January 1, 2026, and signals a strategic move to enhance the quality of healthcare services offered to its...

Continue Reading
ADS-TEC Energy Optimizes Leadership with New CFO Appointment

Updated Category News Views 59

ADS-TEC Energy Announces New CFO Appointment ADS-TEC Energy recently shared exciting news about their executive leadership transition. The company, known for its cutting-edge technology in battery storage solutions and fast charging systems, is making a strategic change in its Chief Financial Officer (CFO) position. This change reflects the organization’s commitment to...

Continue Reading
Sheldon S. Lin Takes Leadership Role in Foot and Ankle Surgery

Updated Category News Views 179

Sheldon S. Lin Takes Leadership Role in Foot and Ankle Surgery Newark Orthopaedic Surgeon to Lead Growth in Foot and Ankle Specialty Foot and ankle orthopaedic surgeon Sheldon S. Lin, MD, has been appointed as the new president of the American Orthopaedic Foot & Ankle Society (AOFAS), an organization dedicated to the advancement of surgical and non-surgical practices for...

Continue Reading